Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.

Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.

Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.

Researchers will investigate the prevalence and disease impact of canine circovirus in dogs.

Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.

Researchers will assess the safety and benefits of intensive, postoperative rehabilitation in dogs recovering from spinal cord injuries.

Researchers will investigate a novel therapeutic target for mammary gland cancer in dogs.

Researchers will create an optical map of the canine genome, an important tool to identify gaps and missing structural components in the current canine genome assembly.

Researchers will determine if genetic factors and co-administered drugs influence the clinical effectiveness of tramadol, a commonly used pain-relief drug in dogs.

Researchers will investigate the role of a small protein released in response to inflammation as a potential new therapy target to control itch and inflammation in dogs with chronic, relapsing allergic skin disease.